MedTrace Logo

RATe Control in Atrial Fibrillation

NCT00313157 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-05-13

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of metoprolol, verapamil, diltiazem and carvedilol on ventricular rate, working capacity and quality of life in patients with chronic atrial fibrillation.

Conditions

Interventions

DRUG

Metoprolol

DRUG

Diltiazem

DRUG

Verapamil

DRUG

Carvedilol

Sponsors & Collaborators

  • Asker & Baerum Hospital

    lead OTHER

Principal Investigators

  • Sara Reinvik Fagertun, MD · Asker and Baerum Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313157 on ClinicalTrials.gov